Gabalex Capital Management Has Decreased Merck & Co (MRK) Position by $2.80 Million as Share Price Declined; As Smucker J M Co (SJM) Stock Declined, Truepoint Trimmed by $34.62 Million Its Stake

May 21, 2018 - By Louis Casey

Merck & Co., Inc. (NYSE:MRK) Logo

Gabalex Capital Management Llc decreased its stake in Merck & Co Inc (MRK) by 33.33% based on its latest 2017Q4 regulatory filing with the SEC. Gabalex Capital Management Llc sold 50,000 shares as the company’s stock declined 4.63% with the market. The hedge fund held 100,000 shares of the health care company at the end of 2017Q4, valued at $5.63 million, down from 150,000 at the end of the previous reported quarter. Gabalex Capital Management Llc who had been investing in Merck & Co Inc for a number of months, seems to be less bullish one the $157.65B market cap company. The stock decreased 0.91% or $0.54 during the last trading session, reaching $58.6. About 4.91M shares traded. Merck & Co., Inc. (NYSE:MRK) has declined 14.94% since May 21, 2017 and is downtrending. It has underperformed by 26.49% the S&P500.

Truepoint Inc decreased its stake in Smucker J M Co (SJM) by 99% based on its latest 2017Q4 regulatory filing with the SEC. Truepoint Inc sold 279,171 shares as the company’s stock declined 2.24% with the market. The institutional investor held 2,818 shares of the packaged foods company at the end of 2017Q4, valued at $350,000, down from 281,989 at the end of the previous reported quarter. Truepoint Inc who had been investing in Smucker J M Co for a number of months, seems to be less bullish one the $12.28B market cap company. The stock increased 0.12% or $0.13 during the last trading session, reaching $108.07. About 501,327 shares traded. The J. M. Smucker Company (NYSE:SJM) has declined 7.89% since May 21, 2017 and is downtrending. It has underperformed by 19.44% the S&P500.

Among 20 analysts covering J. M. Smucker Company (NYSE:SJM), 6 have Buy rating, 5 Sell and 9 Hold. Therefore 30% are positive. J. M. Smucker Company had 74 analyst reports since August 19, 2015 according to SRatingsIntel. Jefferies maintained it with “Hold” rating and $13000 target in Thursday, June 29 report. Susquehanna upgraded The J. M. Smucker Company (NYSE:SJM) on Monday, November 13 to “Positive” rating. Jefferies maintained the shares of SJM in report on Friday, November 17 with “Buy” rating. The company was downgraded on Monday, April 4 by Goldman Sachs. As per Thursday, April 5, the company rating was maintained by Citigroup. Credit Suisse maintained it with “Hold” rating and $126 target in Thursday, June 1 report. The company was upgraded on Wednesday, August 19 by Credit Suisse. The firm earned “Neutral” rating on Thursday, August 24 by JP Morgan. The company was upgraded on Wednesday, September 2 by Credit Agricole. Hilliard Lyons upgraded the stock to “Neutral” rating in Thursday, September 22 report.

Analysts await The J. M. Smucker Company (NYSE:SJM) to report earnings on June, 14. They expect $2.21 EPS, up 22.78% or $0.41 from last year’s $1.8 per share. SJM’s profit will be $251.06M for 12.23 P/E if the $2.21 EPS becomes a reality. After $2.50 actual EPS reported by The J. M. Smucker Company for the previous quarter, Wall Street now forecasts -11.60% negative EPS growth.

Investors sentiment increased to 0.94 in 2017 Q4. Its up 0.05, from 0.89 in 2017Q3. It increased, as 53 investors sold SJM shares while 236 reduced holdings. 94 funds opened positions while 179 raised stakes. 84.66 million shares or 1.41% more from 83.48 million shares in 2017Q3 were reported. Engineers Gate Manager Ltd Partnership holds 0.03% of its portfolio in The J. M. Smucker Company (NYSE:SJM) for 3,705 shares. Benjamin F Edwards owns 13,205 shares. Griffin Asset Mngmt owns 9,985 shares. Speece Thorson Group has 4.18% invested in The J. M. Smucker Company (NYSE:SJM). 6,987 are owned by Hermes Invest Mgmt Ltd. 35,894 are owned by Ledyard Financial Bank. Baker Ellis Asset Lc has 2,387 shares. Vident Investment Advisory Ltd Liability Com holds 6,475 shares. Schwab Charles Invest Inc accumulated 431,558 shares. Sky Investment Gru Limited Liability Corporation stated it has 12,031 shares. Swiss Financial Bank, Switzerland-based fund reported 534,299 shares. State Of Tennessee Treasury Department invested 0.03% of its portfolio in The J. M. Smucker Company (NYSE:SJM). Malaga Cove Lc stated it has 0.65% of its portfolio in The J. M. Smucker Company (NYSE:SJM). Moreover, Cibc Asset Mgmt has 0.01% invested in The J. M. Smucker Company (NYSE:SJM) for 12,783 shares. Westpac Bk Corp holds 0.02% or 6,686 shares.

More notable recent The J. M. Smucker Company (NYSE:SJM) news were published by: Investorplace.com which released: “5 Top Stock Trades for Friday Morning” on May 10, 2018, also Seekingalpha.com with their article: “Packaged food stocks follow Campbell Soup lower” published on May 18, 2018, Crainscleveland.com published: “JM Smucker Co. sets new leadership for pets business” on May 02, 2018. More interesting news about The J. M. Smucker Company (NYSE:SJM) were released by: Bizwest.com and their article: “Smucker to hold more job sessions for Longmont plant” published on May 15, 2018 as well as Investorplace.com‘s news article titled: “7 Consumer Goods Stocks That Will Rise Again” with publication date: May 11, 2018.

Investors sentiment decreased to 0.94 in 2017 Q4. Its down 0.12, from 1.06 in 2017Q3. It dived, as 94 investors sold MRK shares while 631 reduced holdings. 123 funds opened positions while 558 raised stakes. 1.93 billion shares or 1.34% less from 1.96 billion shares in 2017Q3 were reported. Ww Asset Mngmt reported 0.41% stake. Chesapeake Asset Management Ltd Company reported 3.81% of its portfolio in Merck & Co., Inc. (NYSE:MRK). 7,059 were reported by Evanson Asset Management Ltd Liability Corporation. Smith Moore And Company owns 9,071 shares for 0.14% of their portfolio. 840,849 were reported by State Treasurer State Of Michigan. Tiaa Cref Mgmt Ltd holds 10.99 million shares or 0.41% of its portfolio. Pitcairn has invested 0.13% of its portfolio in Merck & Co., Inc. (NYSE:MRK). Cap Advsrs Ok invested in 161,258 shares or 0.53% of the stock. Haverford Financial Inc holds 6,598 shares. Cutler Capital Management Ltd invested 0.18% of its portfolio in Merck & Co., Inc. (NYSE:MRK). Moors & Cabot has invested 0.81% in Merck & Co., Inc. (NYSE:MRK). Foyston Gordon Payne Inc accumulated 74,925 shares or 0.8% of the stock. Samlyn Cap Lc owns 0.56% invested in Merck & Co., Inc. (NYSE:MRK) for 437,020 shares. Kazazian Asset Mngmt Limited Co reported 11,992 shares stake. Meristem Ltd Liability Partnership reported 21,582 shares stake.

More notable recent Merck & Co., Inc. (NYSE:MRK) news were published by: Seekingalpha.com which released: “Congo begins Ebola vaccinations” on May 21, 2018, also Fool.com with their article: “Better Buy: Pfizer Inc. (PFE) vs. Merck (MRK)” published on May 13, 2018, 247Wallst.com published: “What to Look For in the Merck and Pfizer Reports Tuesday Morning” on April 30, 2018. More interesting news about Merck & Co., Inc. (NYSE:MRK) were released by: Seekingalpha.com and their article: “New Ebola outbreak hits Congo” published on May 13, 2018 as well as Livetradingnews.com‘s news article titled: “Merck & Co., Inc. (NYSE:MRK) Trending Upwards” with publication date: May 18, 2018.

Among 24 analysts covering Merck & Co. Inc. (NYSE:MRK), 21 have Buy rating, 0 Sell and 3 Hold. Therefore 88% are positive. Merck & Co. Inc. had 90 analyst reports since August 13, 2015 according to SRatingsIntel. Credit Suisse maintained Merck & Co., Inc. (NYSE:MRK) rating on Wednesday, August 30. Credit Suisse has “Outperform” rating and $74 target. The rating was maintained by Credit Suisse on Wednesday, February 14 with “Outperform”. Barclays Capital maintained the shares of MRK in report on Friday, September 9 with “Overweight” rating. Jefferies maintained the stock with “Hold” rating in Tuesday, June 14 report. On Monday, July 31 the stock rating was maintained by UBS with “Buy”. The firm earned “Sell” rating on Thursday, May 25 by Jefferies. As per Tuesday, June 6, the company rating was maintained by BMO Capital Markets. The stock has “Market Perform” rating by Leerink Swann on Tuesday, February 6. JP Morgan maintained Merck & Co., Inc. (NYSE:MRK) rating on Monday, September 21. JP Morgan has “Overweight” rating and $65 target. The firm has “Hold” rating by Jefferies given on Thursday, August 27.

Analysts await Merck & Co., Inc. (NYSE:MRK) to report earnings on July, 27. They expect $1.04 EPS, up 2.97% or $0.03 from last year’s $1.01 per share. MRK’s profit will be $2.80B for 14.09 P/E if the $1.04 EPS becomes a reality. After $1.05 actual EPS reported by Merck & Co., Inc. for the previous quarter, Wall Street now forecasts -0.95% negative EPS growth.

Merck & Co., Inc. (NYSE:MRK) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Louis Casey

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:








Recent Posts